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The in ¤itro and in ¤i¤o activity of atorvastatin and other 3-hydroxy-3-methylglutaryl
 .  .coenzyme A HMGCoA reductase inhibitors fluvastatin, pravastatin and simvastatin has
been investigated. Atorvastatin, fluvastatin, pravastatin and simvastatin caused a significant
 .and dose-dependent 0.1]50 mM reduction in cell multiplication of vascular smooth muscle
 .cells SMC in cultures associated with the retardation of cycling cells in the G1 and G2rM
 .compartments at 24 h, a phenomenon leading to apoptosis programmed cell death in
several experimental in ¤itro models. The effects on the cell cycle resulted in a strong
inhibition of cell proliferation at 48 h, followed by apoptosis when incubation was pro-
longed to 72 h as assessed by nuclei morphology and cytofluorimetric analysis of DNA. The
apoptotic effect observed for the statins is completely prevented by the addition of
exogenous mevalonate at a 100 mM concentration. In ¤i¤o SMC proliferation was stimu-
lated by applying a silastic collar to the outside surface of carotid arteries in normocholes-
terolemic rabbits in the presence of an anatomically intact endothelium. The positioning of
the collar promoted apoptosis in control vessels as assessed by Terminal Deoxynucleotidyl
 .Transferase-dUTP-Biotin Nick-End Labeling TUNEL assay. The pre-treatment with 5 mg
kgy1 per day of atorvastatin before collar insertion strongly increased the number of
TUNEL-positive cells, suggesting a pro-apoptotic effect of HMGCoA reductase inhibitors
also in ¤i¤o, even though cell DNA rearrangement still needs to be excluded. No apoptotic
signal was detectable in sham operated arteries with no collar in either control or
atorvastatin-treated rabbits. These data indicate that HMGCoA reductase inhibitors effect
on the arterial wall may involve the modulation of both cell proliferation and programmed
cell deaths supporting a possible role of statins in the prevention of early lesion and
restenosis. Q 1997 The Italian Pharmacological Society
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INTRODUCTION
Dynamic and continued ‘stress events’ represented
by either chemical or mechanical risk factors or
alterations of the physiological balance in the arte-
rial wall promote functional endothelium injury and
thus migration and multiplication of smooth muscle
 . w xcells SMC and apoptosis 1 . SMC proliferation
and intimal hyperplasia is a prominent feature in
w xhuman and experimental atherosclerosis 2 .
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Atherosclerosis occurs in the intima at sites of SMC
proliferation and often in the presence of a continu-
ous yet functionally and structurally altered en-
dothelium. Smooth muscle cells contribute to the
lesion by cell accumulation and extracellular matrix
w xproduction and secretion 1 . The control of the
proliferative process is presently considered a
favourable component of potential antiatheroscle-
w xrotic drugs 3 . The occurrence of apoptosis in nor-
mal and especially in rapidly proliferating cell popu-
lations suggests a potential role of this process in the
maintenance of stable numbers of normal cells in
tissues with various degrees of proliferative activity,
w xincluding the arterial wall 4, 5 . Apoptosis is an
important regulator of cell number in the vessel
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wall, balancing cell proliferation and thus helping to
w xmaintain vessel wall architecture 4 . Cell kinetic
studies indicate a tight link between vascular SMC
w xrate of formation and death in normal arteries 6, 7 ,
a link that may be lost upon the development of
w xatherosclerosis 4]6, 8, 9 .
We have recently observed that several 3-hydroxy-
 .3-methylglutaryl coenzyme A HMGCoA reductase
inhibitors are able to affect smooth muscle cell
proliferation in the carotid artery intima of normoc-
holesterolemic rabbits who had a silastic collar
w xplaced on them 10 , by mechanisms independent
from serum lipoprotein lowering, possibly through
w xthe local inhibition of mevalonate biosynthesis 11 .
We also reported that statin-treated C6 glioma cells
show the inhibition of cell cycling in G1 and
arrestrretardation in G2rM both in ¤itro and in
¤i¤o, a phenomenon often associated with apoptosis
w x12 . Furthermore, an apoptotic effect of lovastatin,
an HMGCoA reductase inhibitor, has already been
w x w xdescribed in HL-60 13 , leukaemic 14 and human
w xglioma cells 15 .
In the present study, SMC apoptosis in tissue
culture and in ¤i¤o has been investigated. In ¤i¤o
SMC proliferation was stimulated by the silastic
collar method. The positioning of the collar pro-
motes an early infiltration of the vessel wall by
polymorphonuclear cells and monocytes, followed by
smooth muscle cell replication in the media and
gradual subendothelial smooth muscle cell accumu-
lation, with deposition of extracellular matrix within
w x the neointima 10 . The effect of statins atorvasta-
.tin, fluvastatin, pravastatin and simvastatin on in
¤itro and in ¤i¤o SMC apoptosis has been evaluated.
MATERIALS AND METHODS
Materials
Tissue culture plastics were from Corning Corn-
.ing, NY, USA . Atorvastatin, fluvastatin, pravastatin
and simvastatin were from Parke-Davies, Novartis
 .Basel, Switzerland , Bristol Mayers Squibb and
 .Merck, Sharp and Dohme Rahway, NJ, USA .
Mevalonic acid lactone and all materials for flow
cytometry were from Sigma Chemical Co. St. Louis,
.MO, USA . The TUNEL kit was supplied from
Boeringher-Mannheim.
Cell culture
Smooth muscle cells were cultured according to
w xRoss 16 , from the intima-media layers of the com-
mon carotid of male New Zealand rabbits weighing
 .2]2.3 kg Charles River, Calco, Italy as previuosly
w xdescribed 17 . Cells were maintained in monolayer
culture at 378C in a humidified atmosphere contain-
ing 5% CO in Dulbecco’s minimum essential2
medium Gibco Laboratories, Grand Island, NY,
.USA supplemented with 10% foetal calf serum,
 .penicillin]streptomycin, sodium piruvate Gibco .
Cells were maintained. At confluence, cultures were
repleted by enzym atic dissociation with
 .trypsinrEDTA Gibco . All experiments were per-
formed within the 10th subculture.
Atorvastatin and fluvastatin were diluted in
 .methanol final concentration 0.1% and added in
required amounts to the culture media. Pravastatin
was dissolved in PBS. Simvastatin was added to the
cultures as the sodium salt, obtained from the lac-
w xtone according to the procedure of Kita et al. 18 .
In each experiment, proper control cell dishes in-
 .cubated with methanol 0.1% were included.
Cell viability was determined by the Trypan blue
w xexclusion methods as previously described 19 .
Cell cycle analysis
Approximately 106 cells per experimental condi-
tion were harvested by trypsinization, washed with
 .0.1 M phosphate-buffered saline PBS and subse-
quently fixed in 70% cold ethanol. Propidium iodide
staining and DNA analysis by flow cytometry were
w xcarried out as previously described 12 .
Myocyte proliferation
Myocytes were seeded in triplicate in 35-mm tis-
sue culture dishes at a density of about 150,000 cells
per dish and after 24 h received drug treatment as
described in the Results section. The cell number
was determined using a Coulter counter Coulter
.Instruments, Milan, Italy following tryspinization.
Visualization of apoptotic nuclei
Smooth muscle cells were grown on coverslips and
treated as described in the text. Cells were fixed with
70% cold ethanol and stained with the DNA interca-
lating dye Hoechst 33528, 0.5 mg mly1 in PBS con-
y1 taining 100 mg ml DNase-free RNase A Sigma
.Chemical Co. and 0.1% NP40. The coverslips were
rinsed, air dried and mounted with Permafluor
 .mounting medium Immunon, Pittsburgh, PA, USA .
Fluorescence was visualized using a Zeiss Axioskop
microscope.
Neointimal hyperplasia
 .New Zealand rabbits approx. 2 kg in weight were
used. The animals were randomly separated into two
 .  .groups three animals per group : 1 control ani-
 . y1mals; 2 atorvastatin, 5 mg kg per day continuous
i.p. infusion for 7 days.
At day 5 a silastic collar of 1.5 cm in length was
inserted on the left carotid artery, essentially as
w xdescribed 10 . The contralateral artery was identi-
 .cally manipulated but no collar was left on sham .
Animals were killed 3 days after collar positioning.
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Terminal Deoxynucleotidyl Transferase-
( )dUTP-Biotin Nick-End Labeling TUNEL
assay
Paraffin sections were dewaxed, rehydrated,
 y1 .treated with proteinase K 20 mg ml and blocked
for endogenous peroxidase activity with 3% H O .2 2
After end-labelling for 1 h at 378C according to the
kit instructions, sections were washed in PBS and
incubated with anti-fluorescein antibody conjugated
with horseradish peroxidase complex, rinsed in PBS
and stained with DAB substrate. Apoptotic nuclei
were identified by the presence of fluorescent stain-
ing.
RESULTS
Statin-induced apoptosis: cell cycle distribu-
tion analysis
The DNA histograms obtained from smooth mus-
 .cle cells treated for 24 h with atorvastatin 1]10 mM
showed a dose-dependent drug effect on the cell
 .cycle distribution Fig. 1, upper panel . The entry of
cells into the S phase progressively decreased. At a
concentration above 1 mM the G0rG1 block was
accompanied by an increase of the proportion of
cells in G2rM, as indicated by the decline of the
S:G2rM ratio. When incubation with atorvastatin
was prolonged up to 72 h the G2rM peak declined
coincident with the appearance of a dose-dependent
 .sub-diploid peak sub G1 , typical of apoptotic cells,
starting from a concentration of 5 mM Fig. 1, lower
.panel . The addition of mevalonate to cultured cells
completely abolished the effects of atorvastatin on
 .cell cycle distribution and DNA content Fig. 1 .
Simvastatin, pravastatin and fluvastatin showed a
similar pattern on the cell cycle.
Antiproliferati¤e effect of statins on SMC
Smooth muscle cells were treated in culture with
increasing concentrations of either atorvastatin, flu-
vastatin, pravastatin or simvastatin and the cell num-
ber was determined after 48 h. Exposure to either
statin resulted in a dose-dependent inhibition of cell
growth rates as shown in Fig. 2. A similar pattern,
somehow more effective for simvastatin, was
observed for all statins. The addition of mevalonate
 .100 mM to cells exposed to the statins completely
abolished the antiproliferative effect observed Fig.
.2 .
Fig. 1. In ¤itro effect of atorvastatin on DNA frequency distribution histograms of rabbit SMC. Exponentially growing
 .  .cells were incubated for 24 h upper panel or 72 h lower panel in the presence of various concentrations of atorvastatin.
The DNA content was analyzed by flow cytometry after propidium iodide staining. a, controls; b, 1 mM atorvastatin; c, 5 mM
atorvastatin; d, 10 mM atorvastatin; e, 10 mM atorvastatin plus 100 mM MVA. Percentages of cells in different phases of the
cell cycle are given in each panel. Similar results were obtained in six independent experiments. The sub-dipolid peak in
DNA frequency distribution histograms from 72 h treated cells indicates the presence of apoptotic nuclei.
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Morphological analysis and effect on cell ¤i-
ability in statin-treated cells
The induction of apoptosis by atorvastatin was
also detected in smooth muscle cells by micronucle-
ation after staining with the DNA intercalating dye
 .Hoechst 33528 Fig. 3 . Cell viability, determined by
the Trypan blue exclusion assay, was always greater
than 80% under all experimental conditions data
.not shown .
Statin-induced apoptosis: in ¤i¤o effect
The neointimal hyperplastic lesion composed of
vascular smooth muscle cells was generated by ap-
plying a silastic collar to the outside of normocholes-
terolemic rabbit carotid arteries. Rabbits were killed
24 and 72 h after collar surgery. The positioning of
the collar promoted an early infiltration of the vessel
wall by polymorphonuclear cells and monocytes 24
.h after collar placement , followed by smooth mus-
cle cell replication in the media and a gradual
subendothelial smooth muscle cell accumulation,
with deposition of extracellular matrix within the
neointima. Apoptotic cells were detectable starting
 .24 h after collar positioning. Figure 4 A is an
overview at low magnification illustrating the gen-
eral distribution of TUNEL labelling of nuclei for
internucleosomally degraded DNA indicating apop-
tosis at day 3 in control collared arteries. Labeling
was prominent in the outer media. Carotid arteries
obtained from rabbits treated with either atorvas-
 y1 .tatin or fluvastatin 5 mg kg per day starting 5
days prior to collar insertion revealed a stronger
w  .xTUNEL labelling Fig. 4 B , compared to controls,
which was especially apparent in the outer media
but common also elsewhere. No apoptosis signal was
detectable in arteries with no collar from either
control or statin-treated rabbits.
DISCUSSION
We have recently reported an in ¤itro and in ¤i¤o
inhibition of vascular SMC proliferation by HMG-
CoA reductase inhibitors independent of their
w xhypocholesterolemic properties 10 . The present
study indicates programmed cell death as an additio-
nal possible mechanism for the modulation of the
cellularity of the arterial wall in proliferative
atherosclerotic or restenotic lesions where the SMC
component is predominant. These results and previ-
w xous in ¤itro and in ¤i¤o observations 10, 11 demon-
strate a direct effect by statins on the arterial wall
which merits clinical investigation.
HMGCoA reductase inhibitors have received in-
creasing attention as pharmacological tools for con-
Fig. 2. Dose-dependent effect of different statins on SMC proliferation at 48 h. Exponentially growing cells were
 .  .incubated for 48 h with increasing concentrations of statins in the presence B or absence v of 100 mM mevalonate.
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Fig. 3. Induction of apoptosis by atorvastatin: morpho-
logical analysis of Hoechst 33528-stained nuclei. SMC
were treated for 72 h with 5mM atorvastatin. Cells were
fixed with 70% ice-cold ethanol and stained with Hoechst
33528. Fluorescence was visualized using a Zeiss Axioskop
 .microscope Objective PlanNeofluar 40X . a, untreated
SMC; b, treated SMC. Apoptotic cells are indicated by
arrows.
trolling abnormal cell growth, such as myocyte pro-
w xliferation in atherogenesis 3, 10 or tumor develop-
w xment 12, 20 .
Several in ¤itro and pre-clinical evidence support
the hypothesis of a direct effect of statins on the
w xarterial wall 3 . Recent in ¤itro studies demonstrate
that statins dose-dependently decrease SMC migra-
w xtion and proliferation 17 . Pre-clinical data show
that HMGCoA reductase inhibitors, albeit with dif-
ferent potencies, decrease neointimal proliferation
w xin both hypercholesterolemic 21]24 and normoc-
holesterolemic rabbits without affecting, in this case,
w xplasma cholesterol levels 10 . The latter study sug-
gests that these drugs can directly affect early alter-
ation of wall responses irrespective of plasma lipid
changes. Indeed in ¤i¤o data demonstrate that the
mechanism underlying the antiproliferative effect of
statins is related to the local inhibition of MVA
synthesis within cells of the vascular wall, since local
delivery of MVA fully prevented the inhibitory ef-
Fig. 4. Detection of apoptosis in collared arteries from
normocholesterolemic rabbits 3 days after perivascular
manipulation. Staining with TUNEL demonstrates the
presence of fragmented nuclei. Fluorescence was visual-
ized using a Zeiss Axioskop microscope Objective Plan-
.Neofluar 20X . a, carotid section from the control rabbit;
b, carotid section from a rabbit treated with 5 mg kgy1
day of atorvastatin starting 7 days before collar position-
ing.
w xfect of systemic fluvastatin 11 . It is well known that
mevalonate is the precursor of a complex branched
pathway the major product of which is cholesterol.
However, mevalonate is also the precursor of a
variety of essential non-sterol isoprenoids including:
the polyisoprenoids side chains of heme A and
ubiquinone, involved in oxidative respiration;
dolichol, required for glycoprotein synthesis; and
isopentenyl-adenine, present in some transfer RNAs.
Furthermore, mevalonate is the precursor of two
isoprenoids intermediates, farnesyl-pyrophosphate
 .  .C15 and geranylgeranyl-pyrophosphate C20 , sub-
strates for a post-translational modification in which
the lipid moiety is covalently transferred to cellular
proteins fundamental for cell function secretion, mi-
w xgration and proliferation and proliferation 20 .
In the present study statins were used in rabbit
smooth muscle cell cultures; however, similar results
 .were obtained with human SMC unpublished data .
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Statin concentrations utilized in both rabbit and
human SMC were comparable to the peak plasma
 .concentrations 0.1]1 mM transiently achieved in
the plasma of hypercholesterolemic patients treated
w xwith 160 mg per day of simvastatin 25 . Previous in
¤itro results demonstrated that the inhibition of cell
growth correlates with intracellular HMGCoA re-
ductase activity and takes place as long as mevalo-
nate biosynthesis remains inhibited by at least
w x60]70% 27 . These observations suggest the use of
HMGCoA reductase inhibitors either with very high
in ¤i¤o efficacy or at very high doses and favour an
uninterrupted administration to maintain biological
activity by sustained mevalonate pathway inhibition.
This could translate into a more significant preven-
w xtion of cardiovascular disease 3 .
The results of the present study indicate that
statins play an important role on cell cycle progres-
sion and apoptosis in SMC. In fact, the exposure of
SMC to statins induces at 24 h a dose-dependent
decrease in S phase and an accumulation of the cells
in G2rM, particularly at the highest concentrations.
This results in an inhibitory effect on cell prolifera-
tion at 48 h, followed by apoptosis when incubation
w xis prolonged to 72 h Figs. 1 and 2 . Atorvastatin and
fluvastatin systemic pre-treatment increased the
number of TUNEL positive cells suggesting a pro-
apoptotic effect of HMGCoA reductase also in ¤i¤o,
at least under our experimental conditions, even
though cell DNA rearrangement cannot be com-
pletely excluded.
In conclusion these data, together with previous
results, suggest that the HMGCoA reductase inhibi-
tors effect on the arterial wall may involve modula-
tion of both cell proliferation and apoptotic cell
death. Thus, statins merit further investigation as
preventive approaches to early lesion development
and restenosis.
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